Kim Slocum, KDS Consulting, LLC
Advertisement
Articles by Kim Slocum, KDS Consulting, LLC
Advertisement
Latest Updated Articles
- The downside of pricing specialty pharmaceuticals too high
Published: May 1st 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?
2
Lilly Agreement With Trump Administration Reshapes Patient Access to GLP-1 Obesity Medicines
3
Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio
4
The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients
5
